Clinical Outcomes for Sirolimus-Eluting Stents and Polymer-Coated Paclitaxel-Eluting Stents in Daily Practice
Results From a Large Multicenter Registry
Francesco Saia, MD, PhD*,*,
Giancarlo Piovaccari, MD ,
Antonio Manari, MD ,
Andrea Santarelli, MD ,
Alberto Benassi, MD ,
Enrico Aurier, MD||,
Pietro Sangiorgio, MD¶,
Fabio Tarantino, MD#,
Giuseppe Geraci, MD**,
Giuseppe Vecchi, MD ,
Paolo Guastaroba, MSc ,
Roberto Grilli, MD and
Antonio Marzocchi, MD*
* Istituto di Cardiologia, Università di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy
Unità Operativa di Cardiologia, Ospedale degli Infermi, Rimini, Italy
Unità Operativa di Cardiologia Interventistica, Ospedale S. Maria Nuova, Reggio Emilia, Italy
Laboratorio di Emodinamica, Hesperia Hospital, Modena, Italy
|| Divisione di Cardiologia, Ospedale Maggiore, Parma, Italy
¶ Divisione di Cardiologia, Ospedale Maggiore, Bologna, Italy
# Laboratorio di Emodinamica, Ospedale Morgagni, Forlì, Italy
** Laboratorio di Emodinamica, Policlinico di Modena, Modena, Italy
 Unità Operativa di CardiologiaCentro Interventistico, Ospedale S. Maria delle Croci, Ravenna, Italy
 Agenzia Sanitaria Regionale Regione Emilia-Romagna, Bologna, Italy

View larger version (10K):
[in a new window]
|
Figure 1 Propensity score-adjusted cumulative incidence of (A) death and acute myocardial infarction (AMI), (B) target vessel revascularization (TVR), and (C) major adverse cardiac events (MACE) in the paclitaxel-eluting stent (PES) and in the sirolimus-eluting stent (SES) groups. CI = confidence interval.
|
|

View larger version (21K):
[in a new window]
|
Figure 2 Hazard ratio of 1-year target vessel revascularization (Cox proportional hazards models) in subgroups of patients according to clinical and angiographic characteristics. AMI = actue myocardial infarction; CI = confidence interval; HR = hazard ratio; LAD = left anterior descending coronary artery; NQWMI = nonQ-wave myocardial infarction; PCI = percutaneous coronary intervention.
|
|
|